期刊文献+

胃肠道恶性肿瘤组织中磷脂酰肌醇3-激酶蛋白激酶B和细胞外信号调节蛋白激酶l/2的表达及意义

Expression and significance of PI3K,Akt and ERKl / 2 in gastrointestinal malignant tumor tissue
原文传递
导出
摘要 目的探讨胃肠道恶性肿瘤组织中磷脂酰肌醇3-激酶(PI3K)、蛋白激酶B(Akt)和细胞外信号调节蛋白激酶l/2(ERKl/2)的表达及意义。方法回顾性分析2011年8月至2013年6月间收治的50例胃肠道恶性肿瘤组织标本的临床资料。结果胃肠道恶性肿瘤组织中PI3K、Akt和ERKl/2的阳性表达率和免疫组化评分均明显高于癌旁组织,差异有统计学意义(P<0.05);患者年龄、病理类型、淋巴结转移、病理分期和远处转移情况与PI3K、Akt和ERKl/2的表达无显著相关(P>0.05)。结论胃肠道恶性肿瘤组织中PI3K、Akt和ERKl/2呈高表达,但与临床病理无关,可能参与肿瘤发生发展的早期事件。 Objective To investigate the significance of PI3K,Akt,ERK1/2 expression in gastroin- testinal malignant tumor tissues. Methods 50 cases of gastric bowel malignant tumor tissue samples in our hospital from 2011 August to 2013 June were retrospectively analyzed. Results PI3K,Akt,ERK1/2 posi- tive expression rates and immunohistochemical score in gastrointestinal malignant tumor tissues were signifi- cantly higher than those in noncancerous tissue (P 〈 0.05 ) ; PI3 K, Akt, ERK1/2 expression in gastrointesti- nal malignant tumors were not significantly correlated with patient's age,pathological types,lymph node me- tastasis, distant metastasis and pathological staging(P 〉 0. 05). Conclusion PI3K, Akt, ERK1/2 have high expression in gastrointestinal malignant tumor tissues, but has nothing to do with clinical pathology, and may- be involved in the early events of the occurance and development of tumor.
出处 《中国肿瘤临床与康复》 2014年第4期389-391,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胃肠道恶性肿瘤组织 磷脂酰肌醇3-激酶 蛋白激酶B 细胞外信号调节蛋白激酶l 2 意义 Gastrointestinal malignant tumor tissue PI3K Akt ERK1/2 Significance
  • 相关文献

参考文献10

  • 1CanoeY,InwardsK,KrishmanUnni.诊断外科病理学[M].黄啸原,蔡雷译.北京:北京大学医学出版社,2012:279.
  • 2赵明哲,刘靖华,李玉花,姜勇.ERK信号通路的信号转导调控机制[J].国际病理科学与临床杂志,2009,29(1):15-19. 被引量:51
  • 3马莲环,刘建.ERKl/2的研究进展[M].国外医学,2011,25:279-282.
  • 4殷舞,钟晓刚,黄顺荣,麦威,李雷.PI3K/Akt/mTOR信号通路在大肠腺瘤恶性转化中的表达及意义[J].广东医学,2013,34(2):238-240. 被引量:13
  • 5Ollikainen M, Gylling A, Puputti M, et al. Patterns of PIK3CA al- terations in familial colorectal and endometrial carcinoma [ J]. Int J Cancer, 2012, 121:915-920.
  • 6RingelMD, Hayre N, Saito J, et al. Overexpression and overacti- ration of Akt in thyroid carcinoma [J]. Cancer Res, 2011, 61: 6105- 6111.
  • 7Lopiccolo J, Blumenthal GM, Bernstein WB, et al. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations[J]. Drug Resist Updat, 2008, 11:32-50.
  • 8Michl P, Downwa RI)J. Mechanisms of disease :PI3K/AKT signa- ling in gastrointestinal cancers [ J ]. Z Gastroenterol, 2010, 43 : 1133-1 139.
  • 9Carroll M, Borden KL The oncogene elF4E: using biochemical insights to target cancer [ J ]. J Interferon Cytokine Res, 2013, 33:227-238.
  • 10Pandey MK, Liu G, Cooper TK, et al. Knockdown of cFos sup- presses the growth of human colon carcinoma cells in athymic mice[J]. Int J Cancer, 2012, 130:213-222.

二级参考文献32

  • 1Almog T, Naor Z. Mitogen activated protein kinases (MAPKs) as rugulators of spermatogenesis and spermatozoa functions [ J ]. Mol Cell Endocrinol, 2008, 282 (1-2): 39-44.
  • 2Spickett CM, Pitt AR, Mortice N, et al. Proteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction [J]. Biochim Biophys Acta, 2006, 1764 (12) : 1823-1841.
  • 3McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant, transformation and drug resistance [ J]. Biochim Biophys Acta, 2007, 1773 (8) : 1263-1284.
  • 4Murphy LO, Blenis J. MAPK signal specificity: the right place at the right time [ J ]. Trends Biochem Sci, 2006, 31 (5) : 268-275.
  • 5Msantos SDM, Verveer PJ, Bastiaens PIH. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate [J]. Nat Cell Biol, 2007,9 (3) : 324-330.
  • 6Park ER, Eblen ST, Catling AD. MEK1 activation by PAK: A novel mechanism [J]. Cell Signal, 2007, 19 (7): 1488-1496.
  • 7von Kriegsheim A, Pitt A, Grindlay GJ, et al. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5 [ J ]. Nat Cell Biol, 2006, 8 (9): 1011-1016.
  • 8Marchetti S, Gimond C, Chambard JC, et al. Extracellular signalregulated kinases phosphorylate mitogen activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation [ J ]. Mol Cell Biol, 2005, 25 (2) : 854-864.
  • 9Korotayev K, Chanssepied M, Ginsberg D. ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry [J]. Cell Signal, 2008, 20 (6) : 1221-1226.
  • 10Pullikuth AK, Catling AD. Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: A perspective [ J ]. Cell Signal, 2007, 19 (8): 1621-1632.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部